For targeted therapies, it would be smart to include companies that make targeted diagnostics--such as Vysis , a division of Abbott Labs (nyse: ABT - news - people ) that makes a version of the Herceptin test--from the outset.
FORBES: Why Cancer Drugs Need Genetic Testing